| Mr Caleb David Miner, PA-C | |
|
400 North Highland Ave, Middle Tennessee Medical Center, Murfreesboro, TN 37130 | |
| (904) 953-2000 | |
| Not Available |
| Full Name | Mr Caleb David Miner |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 17 Years |
| Location | 400 North Highland Ave, Murfreesboro, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023295664 | NPI | - | NPPES |
| 293100100 | Medicaid | FL |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Urgent Care Enterprise Llc | 5496998155 | 62 |
News Archive
The American Society of Bariatric Physicians (ASBP) works with physicians so they're better prepared to deal with society's obesity epidemic. Even though people focus on weight loss more in January than any other month, successful weight loss is a year-round long-term initiative that goes far beyond just diet and exercise. The ASBP has highlighted five questions everyone who needs to lose weight should ask their physician.
A study published in PLoS Medicine this week suggests that of women who die during pregnancy and childbirth in sub-Saharan Africa, more may die from treatable infectious diseases than from conditions directly linked to pregnancy.
Allergan, Inc. announced today that the United States District Court for the District of Delaware ruled in favor of Allergan, Inc. in its patent infringement suit against Exela PharmSci, Inc., Exela PharmSci Pvt., Ltd. ("Exela"), Apotex, Inc. and Apotex Corp. ("Apotex") (collectively, the "Defendants") for seeking to market purported generic versions of Allergan's drugs ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15%. Specifically, after a trial in March of 2009, the Court ruled today that all five patents (U.S. Patent Nos. 6,627,210; 6,641,834; 6,673,337; 6,562,873; and 5,424,078) asserted by Allergan are valid and enforceable, that Apotex's proposed generic versions of ALPHAGAN® P 0.1% and 0.15% infringe each of the five patents, and that Exela's proposed generic version of ALPHAGAN® P 0.15% infringes U.S. Patent No. 6,641,834, which was the only patent asserted against it. Pursuant to the Hatch-Waxman Act, the United States Food and Drug Administration is required to delay approval of Defendants' proposed generic products until the last to expire of the infringed patents, which is 2022.
Some Parkinson's Disease patients can suddenly become creative when they take dopamine therapy, producing pictures, sculptures, novels and poetry. But their new-found interests can become so overwhelming that they ignore other aspects of their everyday life, such as daily chores and social activities, according to research published in the March issue of the European Journal of Neurology.
According to survey results gathered from 80 Medical Oncologists in the United States there is an extreme interest in Xalkori, with 75% of respondents stating a high interest in prescribing the product, virtually no physicians stating they have low interest in prescribing the therapy.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Caleb David Miner, PA-C One Vantage Way, Suite B-240, Middle Tennessee Emergency Physicians, Pc, Nashville, TN 37228-1562 Ph: (904) 953-2000 | Mr Caleb David Miner, PA-C 400 North Highland Ave, Middle Tennessee Medical Center, Murfreesboro, TN 37130 Ph: (904) 953-2000 |
News Archive
The American Society of Bariatric Physicians (ASBP) works with physicians so they're better prepared to deal with society's obesity epidemic. Even though people focus on weight loss more in January than any other month, successful weight loss is a year-round long-term initiative that goes far beyond just diet and exercise. The ASBP has highlighted five questions everyone who needs to lose weight should ask their physician.
A study published in PLoS Medicine this week suggests that of women who die during pregnancy and childbirth in sub-Saharan Africa, more may die from treatable infectious diseases than from conditions directly linked to pregnancy.
Allergan, Inc. announced today that the United States District Court for the District of Delaware ruled in favor of Allergan, Inc. in its patent infringement suit against Exela PharmSci, Inc., Exela PharmSci Pvt., Ltd. ("Exela"), Apotex, Inc. and Apotex Corp. ("Apotex") (collectively, the "Defendants") for seeking to market purported generic versions of Allergan's drugs ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15%. Specifically, after a trial in March of 2009, the Court ruled today that all five patents (U.S. Patent Nos. 6,627,210; 6,641,834; 6,673,337; 6,562,873; and 5,424,078) asserted by Allergan are valid and enforceable, that Apotex's proposed generic versions of ALPHAGAN® P 0.1% and 0.15% infringe each of the five patents, and that Exela's proposed generic version of ALPHAGAN® P 0.15% infringes U.S. Patent No. 6,641,834, which was the only patent asserted against it. Pursuant to the Hatch-Waxman Act, the United States Food and Drug Administration is required to delay approval of Defendants' proposed generic products until the last to expire of the infringed patents, which is 2022.
Some Parkinson's Disease patients can suddenly become creative when they take dopamine therapy, producing pictures, sculptures, novels and poetry. But their new-found interests can become so overwhelming that they ignore other aspects of their everyday life, such as daily chores and social activities, according to research published in the March issue of the European Journal of Neurology.
According to survey results gathered from 80 Medical Oncologists in the United States there is an extreme interest in Xalkori, with 75% of respondents stating a high interest in prescribing the product, virtually no physicians stating they have low interest in prescribing the therapy.
› Verified 2 days ago
Benjamin James Stasik, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1800 Medical Center Pkwy Ste 200, Murfreesboro, TN 37129 Phone: 615-896-6800 Fax: 615-895-8890 | |
Emma Grace Aiken, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1574 Medical Center Pkwy, Murfreesboro, TN 37129 Phone: 615-225-2070 | |
Mr. Jason Henry Huddleston, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1800 Medical Center Pkwy, Suite 200, Murfreesboro, TN 37129 Phone: 615-896-6800 Fax: 615-695-1483 | |
Mr. Michael Dawson Maddox, PA C Physician Assistant Medicare: Medicare Enrolled Practice Location: 951 New Salem Hwy, Murfreesboro, TN 37129 Phone: 615-907-0123 Fax: 615-907-0133 | |
Joe A Shaw, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1272 Garrison Dr, Murfreesboro, TN 37129 Phone: 161-589-3448 | |
Lana Danielle Spry, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1574 Medical Center Pkwy Ste 104, Murfreesboro, TN 37129 Phone: 615-225-2070 |